Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated

Why Did I Get Gallstones, and How Common Are They?

At a Glance

Gallstones are common: ultrasound studies find active stones in 6% to 7% of adults; lifetime estimates are 10% to 20%. They form when bile becomes unbalanced; age, genetics, hormones, metabolic changes, rapid weight loss, and some diseases or medicines raise risk, and many people have no symptoms.

Gallstones are very common. While several specific risk factors increase the likelihood of developing them—such as genetics, age, and metabolic changes—many people develop gallstones without any clear, preventable cause. Most people who have gallstones will never experience symptoms or require treatment [1]. However, understanding your risk factors can help you and your doctor make informed decisions about your care.

How Common Are Gallstones?

Gallstone prevalence varies substantially depending on age, sex, geography, and how the data is collected:

  • Current active stones: Recent studies relying strictly on ultrasound screening place the global rate of active gallstones at around 6% to 7% of adults [2].
  • Lifetime burden: Broader estimates that include people who have already had their gallbladders removed place the overall lifetime burden closer to 10% to 20% [3][4].
  • Age and Sex: The risk of developing gallstones increases steadily as you get older [2]. They are also generally more common in women than in men, though this gap can narrow in older age groups [5][2].
  • Geography: Where you live plays a major role. For example, gallstones are particularly common in Western countries and parts of South America, while they tend to be less common in parts of Asia [2][6].

Why Do Gallstones Form?

Gallstones form when the liquid bile stored in your gallbladder becomes unbalanced. This imbalance causes solid crystals to form, which can eventually clump together into stones. The underlying cause depends largely on the type of gallstone you have. (Note: Stone type often cannot be known from a routine ultrasound and is usually only confirmed if the stones are removed.)

Cholesterol Stones

These are the most common type, accounting for up to 80% of stones in Western countries [7]. They form when your liver secretes more cholesterol than your bile can dissolve, causing the excess cholesterol to crystallize [8]. This process is often aided by gallbladder stasis—a condition where the gallbladder does not empty fully or often enough [8].

Pigment Stones

Pigment stones are made primarily from bilirubin, a chemical produced when red blood cells naturally break down. They are divided into two categories:

  • Black pigment stones are associated with chronic conditions that cause a rapid breakdown of red blood cells (a process called hemolysis), such as sickle cell disease, or severe liver scarring called cirrhosis [9][10].
  • Brown pigment stones are often softer and typically form in the setting of infected or stagnant bile in the ducts. This is frequently associated with blockages, structural diseases, or bacterial biofilms [11][12].

Common Risk Factors

Having one or more risk factors increases the chances of developing gallstones, but it is rarely a single event that causes them. Risk factors include:

  • Genetics and Family History: Inherited susceptibility plays a major role. For instance, common variations in certain cholesterol-transporting genes (like the ABCG8 gene) are major contributors to cholesterol stone risk at the population level, though it is hard to quantify the exact risk for one person [11][13].
  • Estrogen and Pregnancy: Female sex hormones increase cholesterol levels in the bile and slow down gallbladder emptying [14]. Because of this, pregnancy, oral contraceptives, and estrogen replacement therapies are all associated with an increased risk of cholesterol stones [15]. Do not stop prescribed contraceptives or hormone therapy without discussing it with your doctor.
  • Weight and Metabolism: Being overweight and having insulin resistance (when your body’s cells don’t respond well to insulin) or diabetes can alter bile composition and reduce gallbladder motility, increasing the risk of cholesterol stones [16].
  • Rapid Weight Loss: Losing a large amount of weight very quickly is a major trigger for cholesterol gallstones [17]. This is common in patients who crash diet or who have recently undergone bariatric (weight-loss) surgery [18]. Gradual, clinician-guided weight loss is generally safer.
  • Digestive and Liver Diseases: Conditions affecting the end of the small intestine (the terminal ileum), such as Crohn’s disease or prior intestinal resections, reduce the body’s ability to recycle bile acids, raising your risk of stones [19].
  • Medications and Nutrition: Intravenous feeding (total parenteral nutrition) and certain medications—including somatostatin analogues and the antibiotic ceftriaxone—can cause bile to thicken into “sludge” or promote stone formation [20][21]. Ceftriaxone-related sludge (pseudolithiasis) is often reversible depending on the dose and duration [20]. Never stop a prescribed medication without speaking to your prescriber.

When to Seek Immediate Medical Attention

Most people with incidentally discovered gallstones do not need treatment. However, if you experience repeated typical attacks, inflammation, or if a stone becomes trapped in the bile duct, you will require medical care [1][22].

Seek emergency medical care if you develop signs of a serious complication, such as:

  • Severe or persistent pain in the upper-right or center of your abdomen (especially if it lasts for several hours)
  • Fever or chills
  • Yellowing of your skin or the whites of your eyes (jaundice)
  • Dark urine or pale-colored stools
  • Repeated vomiting or an inability to keep fluids down
  • Confusion or rapidly worsening illness

Risk Does Not Equal Certainty

When diagnosed with gallstones, it is natural to wonder what you did to cause them. However, it is important to understand that gallstone formation is highly complex. While adopting a healthy lifestyle—such as eating a balanced, high-fiber diet and engaging in regular physical activity—can help lower your risk [23][24], genetics and age play major, unavoidable roles [11][2].

Having a risk factor does not mean you are to blame for your gallstones, and many people develop them simply due to inherited traits and the natural aging process.

Common questions in this guide

How common are gallstones?
Ultrasound-based studies estimate that active gallstones affect about 6% to 7% of adults worldwide. Broader estimates that include people who have had their gallbladders removed place the lifetime burden around 10% to 20%, with rates varying by age, sex, geography, and study methods.
What causes gallstones to form?
Gallstones form when bile stored in the gallbladder becomes unbalanced and cholesterol or bilirubin forms crystals that clump together. Stones are also more likely when the gallbladder does not empty fully or often enough.
What makes a person more likely to develop gallstones?
Risk rises with older age, family history or genetic susceptibility, female hormones, pregnancy, overweight or diabetes, rapid weight loss, certain intestinal or liver diseases, and some medicines. These factors increase the probability of gallstones but do not mean a person caused the condition.
Can gallstones develop even if I have a healthy lifestyle?
Yes. Genetics and aging can contribute even when there is no clear preventable cause, and many people with gallstones never have symptoms. A balanced diet and regular physical activity may lower risk but cannot eliminate it.
Do symptom-free gallstones always need treatment?
No. Most people whose gallstones are found incidentally and who have no symptoms do not need treatment, but the appropriate plan depends on symptoms, stone location, and signs of complications. A clinician can advise whether follow-up or testing is needed.
When should gallstone symptoms be treated as an emergency?
Seek emergency care for severe or persistent upper-right or central abdominal pain, fever or chills, jaundice, dark urine, pale stools, repeated vomiting, inability to keep fluids down, confusion, or rapidly worsening illness. These signs can indicate inflammation, a blocked bile duct, or another serious complication.
Can medicines or pregnancy increase my risk of gallstones?
Yes. Pregnancy, oral contraceptives, estrogen therapy, and some medicines such as ceftriaxone or somatostatin analogues are associated with higher risk, while ceftriaxone-related sludge may be reversible. Do not stop a prescribed medicine or hormone treatment without speaking with the prescriber.

Get notified when new evidence is published on cholelithiasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study.

    Shabanzadeh DM, Sørensen LT, Jørgensen T

    Gastroenterology 2016; (150(1)):156-167.e1.

    PMID: 26375367
  2. 2

    Global Epidemiology of Gallstones in the 21st Century: A Systematic Review and Meta-Analysis.

    Wang X, Yu W, Jiang G, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(8)):1586-1595 doi:10.1016/j.cgh.2024.01.051.

    PMID: 38382725
  3. 3

    Genetics of Gallstones.

    Pęczuła A, Czaplicki A, Przybyłkowski A

    Genes 2025; (16(3)) doi:10.3390/genes16030256.

    PMID: 40149408
  4. 4

    Gastrointestinal microbiome and cholelithiasis: Current status and perspectives.

    Dan WY, Yang YS, Peng LH, et al.

    World journal of gastroenterology 2023; (29(10)):1589-1601 doi:10.3748/wjg.v29.i10.1589.

    PMID: 36970590
  5. 5

    Sex disparities in gallstone disease: insights from the MAUCO prospective population-based cohort study.

    Rodriguez Gatta D, Huidobro L, Petermann-Rocha F, et al.

    BMJ open gastroenterology 2024; (11(1)) doi:10.1136/bmjgast-2024-001457.

    PMID: 39343441
  6. 6

    Age, gender, geographic and clinical differences for gallstones in China: a nationwide study.

    Song Y, Ma Y, Xie FC, et al.

    Annals of translational medicine 2022; (10(13)):735 doi:10.21037/atm-21-6186.

    PMID: 35957733
  7. 7

    Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations.

    Portincasa P, Di Ciaula A, Bonfrate L, et al.

    Internal and emergency medicine 2023; (18(7)):1897-1918 doi:10.1007/s11739-023-03355-z.

    PMID: 37455265
  8. 8

    An update on the pathogenesis of cholesterol gallstone disease.

    Di Ciaula A, Wang DQ, Portincasa P

    Current opinion in gastroenterology 2018; (34(2)):71-80 doi:10.1097/MOG.0000000000000423.

    PMID: 29283909
  9. 9

    [Gallstone complications in sickle cell patients].

    Rambaud E, Ranque B, Pouchot J, Arlet JB

    La Revue de medecine interne 2022; (43(8)):479-486 doi:10.1016/j.revmed.2022.05.006.

    PMID: 35688668
  10. 10

    Gallstone Disease in Cirrhosis-Pathogenesis and Management.

    Mallick B, Anand AC

    Journal of clinical and experimental hepatology 2022; (12(2)):551-559 doi:10.1016/j.jceh.2021.09.011.

    PMID: 35535063
  11. 11

    Gallstones.

    Lammert F, Gurusamy K, Ko CW, et al.

    Nature reviews. Disease primers 2016; (2()):16024 doi:10.1038/nrdp.2016.24.

    PMID: 27121416
  12. 12

    Role of the biliary microbiome in gallstone disease.

    Wang Y, Qi M, Qin C, Hong J

    Expert review of gastroenterology & hepatology 2018; (12(12)):1193-1205 doi:10.1080/17474124.2018.1533812.

    PMID: 30791792
  13. 13

    Genetics of gallstone disease.

    Rebholz C, Krawczyk M, Lammert F

    European journal of clinical investigation 2018; (48(7)):e12935 doi:10.1111/eci.12935.

    PMID: 29635711
  14. 14

    An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13.

    Wang HH, Portincasa P, Liu M, et al.

    Genes 2020; (11(12)) doi:10.3390/genes11121438.

    PMID: 33260332
  15. 15

    A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice.

    DeLeon C, Wang HH, Gunn J, et al.

    Journal of lipid research 2020; (61(5)):767-777 doi:10.1194/jlr.RA119000592.

    PMID: 32127396
  16. 16

    Obesity and Gallstones.

    Parra-Landazury NM, Cordova-Gallardo J, Méndez-Sánchez N

    Visceral medicine 2021; (37(5)):394-402 doi:10.1159/000515545.

    PMID: 34722722
  17. 17

    Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians.

    Portincasa P, Di Ciaula A, Grattagliano I

    Korean journal of family medicine 2016; (37(4)):205-13 doi:10.4082/kjfm.2016.37.4.205.

    PMID: 27468338
  18. 18

    The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: A two-centre retrospective cohort study.

    Manatsathit W, Leelasinjaroen P, Al-Hamid H, et al.

    International journal of surgery (London, England) 2016; (30()):13-8.

    PMID: 27063855
  19. 19

    Gallstones: Physiopathology and treatment of cholelithiasis (part 1).

    Golse N, Boulard P, Ciacio O, et al.

    Journal of visceral surgery 2026; (163(4)):278-290 doi:10.1016/j.jviscsurg.2026.04.004.

    PMID: 42203606
  20. 20

    Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.

    Ubukata M, Ohsawa I, Suzuki H, et al.

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2020; (24(4)):393-399 doi:10.1111/1744-9987.13445.

    PMID: 31626369
  21. 21

    Similarities and differences between biliary sludge and microlithiasis: Their clinical and pathophysiological significances.

    Wang HH, Portincasa P, Liu M, et al.

    Liver research (Beijing, China) 2018; (2(4)):186-199 doi:10.1016/j.livres.2018.10.001.

    PMID: 34367716
  22. 22

    Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches.

    Cianci P, Restini E

    World journal of gastroenterology 2021; (27(28)):4536-4554 doi:10.3748/wjg.v27.i28.4536.

    PMID: 34366622
  23. 23

    Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

    Molina-Molina E, Lunardi Baccetto R, Wang DQ, et al.

    European journal of clinical investigation 2018; (48(8)):e12958 doi:10.1111/eci.12958.

    PMID: 29797516
  24. 24

    A healthy lifestyle pattern and the risk of symptomatic gallstone disease: results from 2 prospective cohort studies.

    Wirth J, Joshi AD, Song M, et al.

    The American journal of clinical nutrition 2020; (112(3)):586-594 doi:10.1093/ajcn/nqaa154.

    PMID: 32614416

This page explains how common gallstones are and why they form for informational purposes only; it does not constitute medical advice. Ask your clinician about your symptoms, risk factors, medications, and need for testing.